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Ethambutol is a common medicine used for the treatment of tuberculosis, which can have serious side
effects, such as retinal and liver dysfunction. Although ethambutol has been reported to impair auto-
phagic ﬂux in rat retinal cells, the precise molecular mechanism remains unclear. Using various
mammalian cell lines, we showed that ethambutol accumulated in autophagosomes and vacuolated
lysosomes, with marked Zn2þ accumulation. The enlarged lysosomes were neutralized and were inﬁl-
trated with Zn2þ accumulations in the lysosomes, with simultaneous loss of acidiﬁcation. These results
suggest that EB neutralizes lysosomes leading to insufﬁcient autophagy, implying that some of the
adverse effects associated with EB in various organs may be of this mechanism.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Ethambutol (EB) is widely used as an anti-mycobacterial agent
and has a diverse range of pharmacological effects [1]. The World
Health Organization (WHO) estimates that approximately 55% of
patients with TB are taking EB as a treatment for TB or for Myco-
bacterium avium infection (Global Tuberculosis Report 2014) [2].
The WHO also estimates that there are around 8.6 million new
cases of TB each year. Patients with TB who are being treated with
EB occasionally develop serious side effects, such as liveruntendo University School of
Japan.
Juntendo University School of
Japan
iki), nhattori@juntendo.ac.jp
Inc. This is an open access article udysfunction, optic neuropathy and visual ﬁeld abnormalities [3].
Multiple types of EB-induced cell damage have been reported,
including Zn2þmislocalization to lysosomes, mitochondrial protein
synthesis blockade, lysosomal membrane permeabilization and the
generation of reactive oxygen species [4,5]. Very recently, EB was
shown to induce cell death of the rat retinal cells due to impaired
autophagy [6]; however, the precise molecular mechanismwas not
fully elucidated.
Autophagy is a key mechanism for cellular homeostasis and
stress adaptation, which facilitates the lysosomal degradation of
intracellular proteins or organelles sequestered within autopha-
gosomes [7e9]. Normal lysosomal acidiﬁcation is essential for
autophagosome-lysosome fusion and the activities of lysosomal
hydrolytic enzymes, both of which are indispensable for autophagy
termination [10e12]. Herein, we reveal that EB is capable of
retarding autophagic ﬂux via inhibition of autophagosome-
lysosome fusion. We further demonstrate that EB induces
enlarged lysosomes to lose their characteristic acidic environment
and form Zn2þ accumulations, suggesting of a novel molecular
mechanism of EB toxicity.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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2.1. Cell lines
Human hepatocarcinoma Huh-7 cells (RIKEN Cell Bank) were
maintained in RPMI1640 medium (SigmaeAldrich) supplemented
with 10% fetal bovine serum (FBS; Sigma Aldrich) and 100 U/ml
penicillin/streptomycin (SigmaeAldrich) at 37 C and 5% CO2.
Human-derived HeLa and SH-SY5Y cells were maintained in Dul-
becco's-modiﬁed Eagle's medium (DMEM) supplemented with 10%
FBS (SigmaeAldrich) and 100 U/ml penicillin/streptomycin (Sigma
Aldrich) at 37 C and 5% CO2. A HeLa GFP-LC3 stable cell line was
established as previously described [13].
2.2. Cell culture in zinc-deﬁcient medium
FBS was mixed with 10% Chelex-100 resin (Bio-Rad) at 4 C
overnight. After centrifugation at 3500 rpm for 5 min, the super-
natant was sterilized using a 0.22-mm ﬁlter. The chelated FBS was
added to culture medium to a ﬁnal concentration of 10% (DMEM-
10% chelated FBS). Huh-7 cells were cultured in the zinc-deﬁcient
medium for 9 days. Meanwhile, cell passaging was performed
once every 2 days.
2.3. Lysosomal pH assay
To observe lysosomal alkalinization, we incubated Huh-7 cells
with 1 mM LysoSensor Green DND-153 (Life Technologies) for
30 min or 5 mg/ml of LysoSensor Yellow/Blue DND-160 (Life
Technologies) for 5 min or 50 nM of LysoTracker Red DND-99 (Life
Technologies) for 30 min in RPMI1640. Cells were washed twice
with phosphate-buffered saline (PBS) and immediately analyzed
using a ﬂow cytometer (FACS Fortessa, BD Biosciences). To quantify
lysosomal pH, we incubated Huh-7 cells with 5 mg/ml of Lyso-
Sensor Yellow/Blue DND-160 for 5 min and assayed with In Cell
Analyzer 1000 (GE Healthcare) according to the manufacturer's
protocol. Fluorescent intensities of each emission (460 nm, 535 nm)
per visual ﬁeld were automatically calculated according to the pH
standard curve.
2.4. Zn 2þ accumulation assay
To observe Zn2þ accumulation in lysosomes, we incubated Huh-
7 cells with 5 mM of FluoZin3 for 30 min. The ﬂuorescence of
FluoZin-3 was analyzed using a ﬂow cytometer (FACS Fortessa BD
Biosciences), and images were acquired on a Zeiss LSM510 META
confocal microscope (63 1.4 NA), at room temperature using Zeiss
LSM510 v.3.2 software. Adobe Photoshop 7.0 (Adobe Systems, Inc.)
was used for subsequent image processing.
2.5. Compounds
Compounds used in this study included EB (SigmaeAldrich,Fig. 1. Ethambutol (EB) blocks autophagosome-lysosome fusion and autophagic ﬂux. A
western blotting with anti-LC3 and anti-actin antibodies. Densitometry analysis of LC3-II lev
for various time periods were subjected to western blotting with anti-LC3 and anti-actin an
Western blotting analysis of Huh-7 cells treated with 250 mg/ml EB for 24 h with anti-p62 an
H. After treatment with or without a saturating concentration of EB (1000 mg/ml) for 24 h
analyzed by western blotting with anti-LC3 and anti-actin antibodies. Densitometry analysis
saturating concentration of EB (1000 mg/ml) for 24 h, with or without 400 nM baﬁlomycin A
antibodies. Densitometry analysis of LC3-II levels relative to actin was performed. K. 24 h af
anti-LC3 (green) antibodies and analyzed by confocal microscopy. The inset shows higher m
LC3 plasmid DNAs, Huh-7 cells were treated with various concentrations of EB for 24 h. Cells
the boxed areas. Scale bar: 10 mm. NS: not signiﬁcant, *p < 0.05, **p < 0.01, ***p < 0.001.E4630), E64d (SigmaeAldrich, E8640), pepstatin A (SigmaeAldrich,
P5318), baﬁlomycin A1 (SigmaeAldrich, B1793), pyrithione (2-
mercaptopyridine N-oxide sodium salt; SigmaeAldrich, H3261),
ZnCl2 (SigmaeAldrich, 229997).
2.6. Plasmid DNAs
tfLC3, encoding mRFP-EGFP-LC3, which was originally gener-
ated by the Yoshimori group, was purchased fromOrigene (Plasmid
21075). Mouse lgp120 was cloned into the mCherry vector.
2.7. Western blotting
Cell pellets were lysed on ice in RIPA buffer (25mM TriseHCl pH
7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% sodium
dodecyl sulfate) in the presence of protease inhibitors (Roche, Basel,
Switzerland) for 20 min. Western blotting was performed accord-
ing to previously published reports [13]. The antibodies used were
as follows: anti-actin (Millipore, clone C4), anti-LC3 (MBL, clone
4E12), anti-p62 (Progen Biotechnik, GP62-C). Antibody signals
were enhanced with chemiﬂuorescent methods from GE Health-
Care as previously described [13].
2.8. Immunoﬂuorescence
Huh-7 cells were seeded on glass coverslips. Twenty-four hours
later, cells were transfected or treated with the relevant com-
pounds. Cells were ﬁxed in 4% paraformaldehyde for 20 min and
then permeabilized with 50 mg/ml digitonin in PBS for 15 min. To
block nonspeciﬁc antigenic sites, cells were incubated with 10% FBS
and 1% bovine serum albumin in PBS for 30 min. Cells were
immunostained with the following antibodies: anti-FLAG (Sigma-
eAldrich, F7425; 1:500), anti-LC3B (1:500) (SigmaeAldrich,
L7543), anti-LAMP1 (1:50) and anti-LAMP2 (1:50) (Development
Studies Hybridoma Bank, clone H4B4). Twenty-four hours later,
cells were incubated with AlexaFluor 488 anti-rabbit IgG (Life
Technologies; 1:500) or AlexaFluor 546 anti-mouse IgG (Life
Technologies; 1:500) for 1 h. Cells were embedded with Vecta-
Shield containing DAPI (Vector Laboratories, H-1200), and images
were acquired on a Zeiss LSM510 META confocal microscope
(63  1.4 NA) at room temperature using Zeiss LSM510 v.3.2 soft-
ware. Adobe Photoshop 7.0 (Adobe Systems Inc.) was used for
subsequent image processing.
2.9. Electron microscopy
Huh-7 cells were seeded on glass coverslips. Twenty-four hours
later, cells were treated with various concentrations of EB for 24 h,
then ﬁxed with 4% glutaraldehyde in 0.1 N sodium-cacodylate at
room temperature for 1 h, and processed for electron microscopy
using a standard protocol. Cells were imaged at
8000  magniﬁcation by transmission electron microscope
(HT7700; Hitachi, Tokyo, Japan). The volume fraction of organelles& B. Huh-7 cells treated with various concentrations of EB for 24 h were analyzed by
els relative to actin levels was performed. C & D. Huh-7 cells treated with 250 mg/ml EB
tibodies. Densitometry analysis of LC3-II levels relative to actin was performed. E & F.
tibodies. Quantiﬁcation of relative p62 levels relative to actin is shown in the graph. G &
, with or without 10 mg/ml E64d and 10 mg/ml pepstatin A for 24 h, Huh-7 cells were
of LC3-II levels relative to actin was performed. I & J. After treatment with or without a
1 for 3 h, Huh-7 cells were analyzed by western blotting with anti-LC3 and anti-actin
ter treatment with 250 mg/ml EB, Huh-7 cells were stained with anti-LAMP1 (red) and
agniﬁcation of the boxed area. Scale bar: 20 mm. L. 24 h after transfection of mRFP-GFP-
were analyzed using live-cell imaging. The upper insets show higher magniﬁcations of
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stitutes for Health, USA).
2.10. Statistical analysis
When only two groups were compared, data were analyzed
using unpaired two-tailed Student's t test. Multiple data sets were
analyzed using one-way analysis of variance with Tukey's post-hoc
test.
3. Results and discussion
3.1. EB blocks autophagosome-lysosome fusion and autophagic ﬂux
Based on a previous report showing that EB blocks autophagic
ﬂux in rat retinal cells, we examined whether this effect is ubiq-
uitous and independent of cell type. First, we examined levels of the
microtubule-associated protein 1 light chain 3 (LC3)-II, a LC3-Fig. 2. Ethambutol (EB) increased the number of enlarged lysosomes and enhanced Zn2
24 h were visualized directly by differential interference contrast (DIC) and stained with
Electron micrographs of Huh-7 cells treated with various concentrations of EB for 24 h. Lowe
D, F). Arrowhead: lysosome; black vertical arrow: endosome; asterisk: enlarged lysosome;
5 mm; black scale bar: 1 mm. H. Percentage total volume of each organelle compared with th
shown in the bar chart. I. Huh-7 cells were transfected with lgp120-mCherry and treated wit
Insets show higher magniﬁcation of the boxed area. Scale bar: 10 mm.phosphatidyl-ethanolamine conjugate and a marker of autopha-
gosomes in various cell lines [12]. After 24 h treatment with EB,
levels of LC3-II increased with 100e1000 mg/ml EB in Huh-7 cells
(Fig. 1A, B), 100e1000 mg/ml EB in HeLa cells and 250 mg/ml EB in
SH-SY5Y cells (Supplementary Fig. S1AeD). EB also increased the
LC3-II/actin ratio in a time-dependent manner in Huh-7 (Fig. 1C, D)
and HeLa cells (Supplementary Fig. S1E, F). This was also seen in
HeLa cells stably expressing GFP-LC3 (Supplementary Fig. S1G)
[14,15]. The expression levels of p62, a well-known autophagic
substrate, were also increased by EB treatment in Huh-7 (Fig. 1E, F),
HeLa and SH-SY5Y cells (Supplementary Fig. S1HeK). LC3-II accu-
mulates following increased upstream autophagosome formation
or impaired downstream autophagosome-lysosome fusion. To
distinguish between these two possibilities, we assayed LC3-II in
the presence of E64D plus pepstatin A (pepA) or baﬁlomycin A1,
which inhibit lysosomal proteases or blocks downstream
autophagosome-lysosome fusion and activation of lysosomal pro-
teases, respectively [16e18]. At 1000 mg/ml EB, a saturationþ accumulation in lysosomes. A. Huh-7 cells treated with or without 250 mg/ml EB for
anti-LAMP1 antibodies and analyzed by confocal microscopy. Scale bar: 10 mm. BeG.
r panels (C, E, G) show higher magniﬁcations of the boxed areas in the upper panels (B,
white arrow: autolysosome; black horizontal arrow: autophagosome. White scale bar:
e total cell volume in Huh-7 cells treated with various concentrations of EB for 24 h are
h EB for 24 h. These cells were stained with FluoZin3 and analyzed by live-cell imaging.
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E64d (10 mg/ml) plus pepstatin A (10 mg/ml) or baﬁlomycin
(400 nM) in Huh-7 cells (Fig. 1GeJ) did not signiﬁcantly increase
the ratios of LC3-II/actin. Taken together, EB-induced LC3-II accu-
mulation results from impaired downstream autophagosome-
lysosome fusion. Immunocytochemical analysis revealed that EB
increases the number of autophagosomes positive for LC3-II near
LAMP1-positive enlarged vesicles (Fig. 1K). To further investigate
autophagosome-lysosome fusion activity and consequent insufﬁ-
cient autophagic ﬂux, we analyzed cells transiently expressing a
tandem ﬂuorescent-tagged LC3 (tfLC3) plasmid DNA, according to a
well-established protocol [19]. This plasmid was tagged with
monomeric red ﬂuorescent protein (mRFP) and green ﬂuorescent
protein (GFP). After EB treatment, there was no signiﬁcant differ-
ence in the numbers of autolysosomes positive for mRFP only;
however, the numbers of autophagosomes positive for both mRFP
and GFP were signiﬁcantly increased in a dose-dependent manner
(Fig. 1L). These results indicate that high concentrations of EB
treatment blocked autophagic ﬂux because autophagosomes were
unable to fuse with lysosomes, thus resulting in the accumulation
of autophagosomes.Fig. 3. Ethambutol (EB) treatment inhibits lysosomal acidiﬁcation via enhancement of Z
stained with 1 mM LysoSensor Green DND-153 for 30 min, and were analyzed by ﬂow cytom
stained with 5 mg/ml LysoSensor Yellow/Blue for 5 min. Lysosomal pH was measured usin
concentrations of EB for 24 h were stained with 50 nM LysoTracker Red (Red) for 30 min and3.2. EB increases the number of enlarged lysosomes containing
increased concentrations of Zn2þ
Because EB induced multiple large structures positive for the
lysosomal marker LAMP1 (Supplementary Fig. S2A), we investigated
lysosomal morphological changes in more detail by electron micro-
scopy. As shown in Fig. 2A-F, the number of normal lysosomes
(Fig. 2A, B: highly-dense organelles indicated by the arrowhead)
around the nucleus gradually decreased in an EB dose-dependent
manner. In contrast, the nucleus was surrounded by low-density
enlarged lysosomes (Fig. 2D, F: asterisk), which were similar to
those seen with chloroquine treatment, an anti-malarial agent that
inhibits lysosomal acidiﬁcation [20]. Although the number of normal
lysosomes was signiﬁcantly decreased, that of enlarged lysosomes
wasmarkedly increased in a dose-dependent manner, as revealed by
stereotaxic methods (Fig. 2G). A previous study revealed that lyso-
somal Zn2þ accumulation was enhanced by EB [5], so, we checked if
EB changes the intracellular distribution and concentration of Zn2þ
using FluoZin3® reagent, which accumulates in organelles in a Zn2þ
concentration-dependent manner in cells overexpressing mCherry-
lgp120, a mouse homolog of human LAMP1. We observed thatn2þ uptake into lysosomes A & B. Huh-7 cells treated with 250 mg/ml EB for 24 h were
etry. **p < 0.01. C. Huh-7 cells treated with various concentrations of EB for 24 h were
g In Cell Analyzer 1000. **p < 0.01, ***p < 0.001. D. Huh-7 cells treated with various
5 mM FluoZin3 (Green) for 30 min, and analyzed by live-cell imaging. Scale bar: 5 mm.
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increased FluoZin3 ﬂuorescence in cells treated with EB (Fig. 2H). In
addition, ﬂowcytometry analysis revealed that intracellular FluoZin3
intensity was signiﬁcantly increased by EB in a dose-dependent
manner (Fig. 2I). We conﬁrmed that EB induced FluoZin3 accumu-
lation in cells cultured in either plain DMEM or Zn2þ-deﬁcient me-
dium, suggesting that lysosomal Zn2þ accumulation was caused byFig. 4. Pyrithione-induced Zn2þ inﬂux to the cytoplasm results in lysosomal neutraliza
with lgp120-mCherry and treated with or without 10 mM pyrithione (PT, Zn ionophore) and
live-cell imaging. Scale bar: 10 mm. B & C. After 1 h treatment with or without 10 mM PT a
FluoZin3 and analyzed by live-cell imaging. Time-lapse images were obtained every 10 minintracellular redistribution (Supplementary Fig. S2B).3.3. EB treatment inhibits lysosomal acidiﬁcation via enhanced
lysosomal uptake of Zn2þ
We next investigated whether lysosomal pH was affected by EB
treatment in Huh-7 cells using various LysoSensor agents [21]. EBtion associated with lysosomal Zn2þ accumulation. A. Huh-7 cells were transfected
with or without 500 mM ZnCl2. These cells were stained with FluoZin3 and analyzed by
nd with or without 500 mM ZnCl2, Huh-7 cells were stained with LysoTracker Red and
(C). Scale bar: 20 mm.
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of LysoSensor DND-153, which only ﬂuoresces green in neutral
organelles (Fig. 3A, B). The numbers of cells positive for LysoSensor
Blue, which ﬂuoresces blue in neutral organelles, were increased by
EB treatment (Supplementary Fig. S3A, B). Similarly, using Lyso-
Sensor Yellow/Blue with the IN Cell Analyzer 1000®, we conﬁrmed
that the mean lysosomal pH was signiﬁcantly increased in a dose-
dependent manner by up to 250 mg/ml EB (Fig. 3C). We also found
that 50 or 100 mg/ml EB treatment for 24 h increased the number of
lysosomes positive for both FluoZin3 and LysoTracker Red, which
exhibited decreased intensity in lysosomes with higher pHs
(Fig. 3D). Although enlarged vacuoles were observed following
250 mg/ml EB treatment, most were only positive for FluoZin3, but
not for LysoTracker Red, indicating that EB induced Zn2þ accumu-
lated in lysosomes, while simultaneously elevating their luminal
pH.
3.4. Zn2þ ionophore-induced intralysosomal Zn2þ accumulation
and lysosomal neutralization
To further investigate the association of lysosomal neutraliza-
tion and Zn2þ storage in lysosomes, we examined the phenomena
following the forced upregulation of the cytoplasmic Zn2þ con-
centration using pyrithione (PT), which activates Zn2þ uptake into
the cytoplasm [22], in cells overexpressing lgp120-mCherry. No
apparent FluoZin3 ﬂuorescence was detected in cells without PT
treatment; however, vesicles positive for FluoZin3 and mCherry
were detected, implying that Zn2þ accumulated in the lysosomes
(Fig. 4A). Furthermore, lysosomes in cells treated with PT and
cultured in Zn2þ-enriched DMEM were much more enlarged than
cells treated only with PT. To monitor whether the lysosomal
accumulation of Zn2þ was associated with lysosomal neutraliza-
tion, we analyzed changes in the ﬂuorescent intensity of Lyso-
Tracker Red. As expected, PT treatment in cells cultured in Zn2þ-
enriched DMEM signiﬁcantly reduced lysosomal LysoTracker Red
intensity compared with PT treatment alone (Fig. 4B). Finally, to
conﬁrm this phenomenon under continuous observation, we per-
formed live-cell imaging experiments. Although cells cultured in
Zn2þ-enriched DMEM without PT showed static LysoTracker Red
ﬂuorescence, those cultured the same medium with PT caused
rapid inﬁltration of FluoZin3 into lysosomes, with simultaneous
loss of LysoTracker ﬂuorescence within 10 min (Fig. 4C). These re-
sults indicate that high concentrations of intracellular Zn2þ induced
lysosomal neutralization, in accordance with their function as zinc-
buffering organelles, which is also consistent with our EB treatment
results.
In this study, we revealed that autophagy was inhibited in
various cell lines, including Huh-7 (hepatocellular carcinoma), HeLa
(uterus cervical carcinoma) and SH-SY5Y (human neuroblastoma)
cells, indicating that this phenomenon could be ubiquitous,
resulting in systemic side effects. Furthermore, we determined the
mechanism of EB-induced lysosomal neutralization and Zn2þ
accumulation, which leads to autophagic insufﬁciency.
Zn2þ transport across the plasma membrane and limiting
membranes of intracellular organelles is mediated by two separate
families of integral membrane proteins: the Zrt and Irt-like proteins
(Zip), also known as solute-linked carrier 39A (SLC39A) family
members, and the zinc transporter (ZnT)/cation diffusion facili-
tator/SLC30 family members [23,24]. Zip proteins accelerate Zn2þ
uptake into the cytosol from the extracellular space or from the
luminal compartments of cytoplasmic vesicles and organelles. In
contrast, most ZnT family members facilitate the removal of Zn2þ
from the cytosol, by either transporting it out of the cell or into the
lumen of vesicles and organelles. However, no apparent ZnTs have
been identiﬁed that regulate lysosomal acidiﬁcation. Therefore,future experiments should be performed focusing on ZnTs localized
in lysosomes to determine the overall mechanism of lysosomal pH
control.
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